EANS-News: Marseille-Kliniken AG improves its earnings in first quarter 2011/2012

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Financial Figures/Balance Sheet/Preliminary quarterly results

Subtitle: - EBIT improved by 50.0 percent to EUR 3.0 million
- Revenues stable at EUR 48.2 million
- Substantial EBIT increase in the current financial year expected

Hamburg (euro adhoc) - 7 November 2011 - Marseille-Kliniken AG
reported a substantial rise in profitability in the first quarter of
the 2011/2012 financial year (1 July through 30 September 2011).
According to the preliminary figures, EBIT rose by 50.0 percent to
EUR 3.0 million (previous year: EUR 2.0 million). The occupancy rate
rose to 88.5 percent in the first quarter of 2011/2012 after an
average of 87.1 percent in the past financial year. Revenues at EUR
48.2 million (previous year: EUR 49.1 million) remained at a stable
level. "Earnings in the first quarter 2011/2012 showed that the
Group's strategic reorientation is taking hold and profitability
could be clearly improved. We expect this development to stabilise in
the whole financial year," says Michael Thanheiser, chairman of
Marseille-Kliniken AG.

In the lapsed 2010/2011 financial year, Marseille-Kliniken AG
reinforced its focus towards the core competencies in inpatient and
outpatient care for the elderly, strengthened its quality leadership,
and introduced a new, decentralised management structure. Moreover a
programme carried out to optimise costs also played a role in
supporting the company's economic recovery. In connection with this,
the company broke even in the first quarter of 2011/2012 with the
construction of AMARITA Hamburg-Mitte, amongst other factors.
Marseille-Kliniken AG operates a total of 60 care facilities across
Germany, with a sales capacity of 7,960 beds.

Against the backdrop of the first quarter results, Marseille-Kliniken
AG has confirmed its forecast for the 2011/2012 financial year, which
calls for Group EBIT well above the previous year's level with a
revenue increase. The optimisation of the core business of nursing
care and the improvement in financing will remain the strategic focus
here.

As announced, Marseille-Kliniken AG began the issuance of a bond for
up to EUR 15.0 million on 31 October 2011. This is offered to German
and European institutional investors in the scope of a private
placement. The bond has a term of two years as well as an interest
rate of 9.5 percent in the first year and 12.5 percent in the second
year. It can be repaid in full after the first year.

Marseille-Kliniken AG will release the full results for the first
quarter of the 2011/2012 financial year on 16 November 2011. The
corresponding quarterly report will then be made available to the
public on the company's website at www.marseille-kliniken.com.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Stuttgart, Düsseldorf, regulated dealing: Hamburg
language: English